» Articles » PMID: 35421904

Extracellular Vesicles and Their MicroRNA Cargo in Ischaemic Stroke

Overview
Journal J Physiol
Specialty Physiology
Date 2022 Apr 14
PMID 35421904
Authors
Affiliations
Soon will be listed here.
Abstract

Acute ischaemic stroke (AIS) is a leading cause of death and disability. MicroRNAs (miRNAs) are short non-coding RNAs which hold the potential to act as a novel biomarker in AIS. The majority of circulating miRNAs are actively encapsulated by extracellular vesicles (EVs) produced by many cells and organs endogenously. EVs released by mesenchymal stem cells (MSCs) have been extensively studied for their therapeutic potential. In health and disease, EVs are vital for intercellular communication, as the cargo within EVs can be exchanged between neighbouring cells or transported to distant sites. It is clear here from both current preclinical and clinical studies that AIS is associated with specific EV-derived miRNAs, including those transported via MSC-derived EVs. In addition, current studies provide evidence to show that modulating levels of specific EV-derived miRNAs in AIS provides a novel therapeutic potential of miRNAs in the treatment of stroke. Commonalities exist in altered miRNAs across preclinical and clinical studies. Of those EV-packaged miRNAs, miRNA-124 was described both as an EV-packaged biomarker and as a potential EV-loaded therapeutic in experimental models. Alterations of miRNA-17 family and miRNA-17-92 cluster were identified in preclinical, clinical and MSC-EV-mediated neuroprotection in experimental stroke. Finally, miRNA-30d and -30a were found to mediate therapeutic effect when overexpressed from MSC and implicated as a biomarker clinically. Combined, EV-derived miRNAs will further our understanding of the neuropathological processes triggered by AIS. In addition, this work will help determine the true clinical value of circulating EV-packaged miRNAs as biomarkers of AIS or as novel therapeutics in this setting.

Citing Articles

BMSCs-derived small extracellular vesicles antagonize cerebral endothelial Caveolin-1 driven autophagic degradation of tight-junction proteins to protect blood-brain barrier post-stroke.

Li Y, Quan X, Hu J, Han Y, Chen J, Zhou M Int J Biol Sci. 2025; 21(2):842-859.

PMID: 39781452 PMC: 11705626. DOI: 10.7150/ijbs.101937.


Connecting cellular mechanisms and extracellular vesicle cargo in traumatic brain injury.

Ollen-Bittle N, Roseborough A, Wang W, Wu J, Whitehead S Neural Regen Res. 2024; 19(10):2119-2131.

PMID: 38488547 PMC: 11034607. DOI: 10.4103/1673-5374.391329.


Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae.

Mone P, Jankauskas S, Manzi M, Gambardella J, Coppola A, Kansakar U J Pharmacol Exp Ther. 2024; 389(1):34-39.

PMID: 38336381 PMC: 10949163. DOI: 10.1124/jpet.122.001253.


Mechanism of adipose tissue-derived stromal cell-extracellular vesicles in treating oral submucous fibrosis by blocking the TGF-β1/Smad3 pathway via the miR-760-3p/IGF1R axis.

Wang F, Jiang L, Liu P, Jiang Y Biomol Biomed. 2023; 24(4):827-839.

PMID: 38059910 PMC: 11293217. DOI: 10.17305/bb.2023.9944.


Modulation of miR-146b Expression during Aging and the Impact of Physical Activity on Its Expression and Chondrogenic Progenitors.

Dalle Carbonare L, Minoia A, Braggio M, Bertacco J, Piritore F, Zouari S Int J Mol Sci. 2023; 24(17).

PMID: 37685971 PMC: 10488278. DOI: 10.3390/ijms241713163.


References
1.
Paolicelli R, Bergamini G, Rajendran L . Cell-to-cell Communication by Extracellular Vesicles: Focus on Microglia. Neuroscience. 2018; 405:148-157. DOI: 10.1016/j.neuroscience.2018.04.003. View

2.
Li W, Shi L, Hu B, Hong Y, Zhang H, Li X . Mesenchymal Stem Cell-Based Therapy for Stroke: Current Understanding and Challenges. Front Cell Neurosci. 2021; 15:628940. PMC: 7899984. DOI: 10.3389/fncel.2021.628940. View

3.
Banks W, Sharma P, Bullock K, Hansen K, Ludwig N, Whiteside T . Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation. Int J Mol Sci. 2020; 21(12). PMC: 7352415. DOI: 10.3390/ijms21124407. View

4.
Huang M, Xiao C, Zhang L, Li L, Luo J, Chen L . Bioinformatic Analysis of Exosomal MicroRNAs of Cerebrospinal Fluid in Ischemic Stroke Rats After Physical Exercise. Neurochem Res. 2021; 46(6):1540-1553. DOI: 10.1007/s11064-021-03294-1. View

5.
Kim M, Lee Y, Lee M . Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model. Nanoscale. 2021; 13(33):14166-14178. DOI: 10.1039/d0nr07516g. View